Hyalex Orthopaedics Increases Series A Total to $33MM

Hyalex Orthopaedics raised additional funding in expansion of its Series A, increasing from US $16MM to $33MM. The company is developing HYALEX™ synthetic polymer that is designed to mimic hyaline cartilage,

HYALEX material can maintain an extremely low wear profile, even at high loads such as those in human joints. Hyalex seeks to retain the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us